Skip to content
Open access

Extracellular Vesicles from Human Induced Pluripotent Stem Cells Reduce Lung Ischemia-Reperfusion Injury via Cytoprotective Mechanisms in both 2D Cultures and a Human Airway Organoid Model

Oct 2026 · International Journal on Biological Sciences · Vol 22, pp. 8571 - 8590 · 0 citations · 81 references
Medicine

TL;DR

It is demonstrated that hiPSC-EV exert broad cytoprotective effects in pulmonary IRI through coordinated regulation of inflammation, oxidative stress, and cell death through coordinated regulation of inflammation, oxidative stress, and cell death.

Abstract

Lung transplantation (LTx) remains the only curative option for patients with end-stage pulmonary diseases. However, long-term outcomes are compromised by ischemia-reperfusion injury (IRI), a major contributor to primary graft dysfunction and chronic lung allograft impairment. Current pharmacological and technological strategies provide only partial protection, highlighting the need for novel therapeutic approaches. In this study, we investigated the therapeutic potential of extracellular vesicles derived from human induced pluripotent stem cells (hiPSC-EV) in a two-dimensional (2D) in vitro model of pulmonary IRI using A549 lung epithelial cells. To better recapitulate the in vivo airway microenvironment, we also employed a human airway organoid (hAO) model. Proteomic analysis of hiPSC-EV identified 1,698 proteins enriched in pathways relevant to apoptosis regulation, oxidative stress responses, and inflammatory signaling. In the 2D IRI model, the administration of hiPSC-EV during reperfusion significantly improved cell viability, reduced lactate dehydrogenase (LDH) release, attenuated reactive oxygen species (ROS) accumulation, and decreased apoptosis and necrosis. Furthermore, hiPSC-EV downregulated pro-inflammatory mediators (NFkB1, TNFα, IL1β, IL8, MCP1) while upregulating anti-inflammatory and anti-apoptotic key factors (IL1RA, BCL2). In the 3D model, hiPSC-EV administration preserved organoid structure and viability under IRI conditions, attenuated transcriptional and protein-level expression of pro-inflammatory and oxidative stress markers (IL1β, IL8, HMGB1, HMOX1), and enhanced anti-inflammatory (IL10) and cytoprotective (HSP27, HSP70) responses. Immunofluorescence further revealed that hiPSC-EV reduced activation of apoptotic and pyroptotic pathways. Moreover, intravenous administration of hiPSC-EV in mice showed no adverse safety signals, including tumorigenicity. Together, these findings demonstrate that hiPSC-EV exert broad cytoprotective effects in pulmonary IRI through coordinated regulation of inflammation, oxidative stress, and cell death. Their scalability, reproducibility, and favorable safety profile underscore their promise as innovative cell-free therapeutics to improve outcomes in LTx.

Read PDF

Similar papers

Open access Oct 2026

Exosome-mediated immunomodulatory and barrier-protective responses of adipose-derived mesenchymal stem cells in oleic acid-induced acute lung injury

Both ADMSCs and their exosomes showed therapeutic potential in ALI, with stem cells providing superior histopathological recovery, although no significant differences were observed in IL-6, IL-10, or VEGF expression.

Gamze Ayar, Badel Ince, K. Büyükafşar et al. · 0 citations
Oct 2026

GPC5 regulates human umbilical cord mesenchymal stem cell function and exosome signaling mediates AhR pathway repair of cigarette smoke induced lung injury.

Cigarette smoking (CS) is a major cause of chronic lung injury. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and secreted exosomes (exos) hold therapeutic potential for lung repair. However, improving hUC-MSCs utilization remains a crucial clinical issue. Glypican-5 (GPC5) was recently found to participate in...

Peng Wang, Yu Dong, Hua Guo et al. · 0 citations
Open access Oct 2026

A cell-free therapeutic strategy using MSC-derived exosomes and activated platelet lysate for acute kidney injury induced by rhabdomyolysis

Rhabdomyolysis-induced acute kidney injury (AKI) is primarily driven by myoglobin-mediated tubular toxicity, leading to pronounced oxidative stress, inflammation, and apoptosis. Given the limited availability of effective targeted therapies, this study aimed to evaluate the efficacy of a combined cell-free approach usi...

Neveen A. Salem, Shaimaa A. ElShebiney, E. Salem et al. · 0 citations
Open access Oct 2026

Transcriptomics Reveals Mesenchymal Stem Cell-Derived Exosomes Activate Hepatocyte Longevity-Regulating Pathway in Acute-On-Chronic Liver Failure

Integrative transcriptomic analysis revealed that MSC-exos activate the FoxO/Cat axis through miRNA-mRNA interactome remodeling, thereby orchestrating coordinated antioxidant, pro-autophagic, and anti-senescence effects alongside immune microenvironment reprogramming in liver failure.

Deng-Na Lin, Yong-Qi Zhang, Hai-Xia Sun et al. · 0 citations
Open access Sep 2026

Therapeutic Effects of Wnt5a-Overexpressing Bone Marrow Mesenchymal Stem Cells on Endothelial Barrier Repair in Acute Lung Injury

Background: Acute lung injury/acute respiratory distress syndrome (ALI/ARDS), a common complication of sepsis, is critically characterized by disruption of the alveolar–capillary barrier. The use of mesenchymal stem cells (MSCs) has emerged as a promising therapeutic strategy for ARDS owing to their potent paracrine ef...

Shi-Qi Li, Wan-Mei He, Man-Liang Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.